Drug Resistance to Famitinib and Camrelizumab
1 clinical trials · Condition
◉ Watch Drug Resistance to Famitinib and Camrelizumab
| Record | Firm | Date |
|---|---|---|
| Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab (NCT03919539) | Peking University People's Hospital | 2019-12-01 |
Track Drug Resistance to Famitinib and Camrelizumab automatically
Every clearance here is in the API, with alerts when new ones post.